| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.00046 | 1 |